For
the nine months ended September 30, 2025 and 2024, the calculations of basic and diluted loss per share are the same because potential
dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:
Schedule of Potentially Dilutive Securities
| | |
September 30, 2025 | | |
September 30, 2024 | |
| Warrants | |
| 91,549 | | |
| 91,549 | |
| Options | |
| 47,072 | | |
| 21,385 | |
| Convertible note payable | |
| - | | |
| 307,472 | |
| Common stock equivalent of Series A Convertible Preferred stock | |
| 125 | | |
| 125 | |
| Total | |
| 138,746 | | |
| 420,531 | |
| Anti-dilutive Securities | |
| 138,746 | | |
| 420,531 | |
|